**人工智能医疗科技公司Carlsmed完成5250万美元C轮融资，加速个性化手术平台发展**
近日，全球领先的人工智能个性化手术医疗科技公司Carlsmed宣布，已成功完成由B Capital和US Venture Partners联合领投的5250万美元C轮融资。此轮融资的顺利完成，标志着Carlsmed在医疗科技领域的创新与应用迈入了新的阶段。
据BusinessWire报道，此次筹集的资金将主要用于推进Carlsmed的核心产品——aprevo ®个性化脊柱手术平台的商业化进程，特别是针对腰椎融合手术的应用。aprevo ®平台凭借其人工智能技术，为患者提供高度定制化的手术方案，大大提升了手术精准度和患者康复效果。
此外，Carlsmed还透露，计划将部分资金用于aprevo ®平台在颈椎融合手术领域的研发，预计该新应用将于2025年正式推出。这一举措将进一步扩展Carlsmed在脊柱手术领域的影响力，为更多患者带来福音。
Carlsmed的这一轮融资，不仅体现了资本市场对其技术实力和市场前景的认可，也预示着人工智能在医疗健康领域的广泛应用和深远影响。公司表示，将继续致力于创新医疗解决方案，以科技力量推动医疗手术的个性化和精准化，改善患者的生活质量。
英语如下：
**News Title:** “Carlsmed Raises $52.5 Million in Series C Funding to Accelerate the Development of its Personalized Spine Surgery Platform, aprevo ®”
**Keywords:** Carlsmed, Artificial Intelligence, Surgical Platform
**News Content:**
**AI-driven medical technology company Carlsmed completes $52.5 million Series C funding round to hasten development of personalized surgery platform**
Recently, Carlsmed, a global leader in artificial intelligence (AI)-powered personalized surgery, announced it has successfully closed a $52.5 million Series C funding round co-led by B Capital and US Venture Partners. This financing milestone signifies a new chapter in Carlsmed’s innovation and application within the medical technology sector.
According to BusinessWire, the funds raised will primarily support the commercialization of Carlsmed’s flagship product, the aprevo ® personalized spine surgery platform, particularly for lumbar fusion surgeries. The aprevo ® platform, utilizing AI technology, offers highly tailored surgical plans for patients, enhancing surgical precision and patient recovery outcomes.
Additionally, Carlsmed disclosed plans to allocate part of the funds to the development of aprevo ® for cervical fusion surgeries, with an expected launch in 2025. This expansion will augment Carlsmed’s influence in the spinal surgery domain, benefiting a broader patient population.
The current funding round underscores the capital market’s endorsement of Carlsmed’s technological prowess and market potential, as well as the growing significance of AI in the healthcare industry. The company has vowed to continue its dedication to innovative medical solutions, leveraging technology to advance personalized and precise surgeries, thereby improving patients’ quality of life.
【来源】https://www.businesswire.com/news/home/20240318820510/en/Carlsmed-Raises-52.5M-in-Series-C-Financing-to-Advance-Personalized-Spine-Surgery
Views: 1